Alignment Healthcare (NASDAQ:ALHC) Stock Rated Hold in New Coverage at Needham & Company LLC

Needham & Company LLC assumed coverage on shares of Alignment Healthcare (NASDAQ:ALHC) in a research report report published on Wednesday morning, MarketBeat reports. The brokerage issued a hold rating on the stock.

Several other analysts have also commented on the company. The Goldman Sachs Group reaffirmed a “buy” rating and set a $12.00 target price on shares of Alignment Healthcare in a report on Thursday, October 22nd. Scotiabank set a $9.00 price target on Alignment Healthcare in a report on Friday, October 9th. Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. UBS Group lowered their price objective on Alignment Healthcare from $22.00 to $9.00 and set a “neutral” rating on the stock in a research report on Monday, October 12th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Alignment Healthcare from $22.00 to $10.00 and set an “overweight” rating on the stock in a research note on Friday, October 9th. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $14.27.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC opened at $7.27 on Wednesday. Alignment Healthcare has a 52 week low of $6.01 and a 52 week high of $25.12. The business’s 50 day moving average price is $9.87 and its 200 day moving average price is $16.82. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 1.22. The firm has a market cap of $1.51 billion, a P/E ratio of 55.93 and a beta of 1.14.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, October 29th. The company reported ($0.04) EPS for the quarter, meeting the consensus estimate of ($0.04). The business had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.31 billion. Alignment Healthcare had a net margin of 0.59% and a return on equity of 13.32%. The business’s quarterly revenue was up 36.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.02 EPS. On average, sell-side analysts expect that Alignment Healthcare will post 0.14 earnings per share for the current year.

Insider Activity

In related news, President Dawn Maroney sold 122,707 shares of Alignment Healthcare stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $12.68, for a total value of $1,555,924.76. Following the completion of the transaction, the president owned 794,606 shares in the company, valued at $10,075,604.08. The trade was a 13.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO John E. Kao sold 27,400 shares of the company’s stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $13.00, for a total value of $356,200.00. Following the completion of the transaction, the chief executive officer directly owned 590,766 shares of the company’s stock, valued at $7,679,958. The trade was a 4.43% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 1,061,967 shares of company stock valued at $13,642,490. Insiders own 5.20% of the company’s stock.

Institutional Trading of Alignment Healthcare

Institutional investors have recently bought and sold shares of the business. Oregon Public Employees Retirement Fund lifted its position in shares of Alignment Healthcare by 11.7% in the third quarter. Oregon Public Employees Retirement Fund now owns 41,900 shares of the company’s stock valued at $342,000 after acquiring an additional 4,400 shares in the last quarter. Vise Technologies Inc. increased its position in shares of Alignment Healthcare by 31.2% during the third quarter. Vise Technologies Inc. now owns 12,163 shares of the company’s stock worth $99,000 after purchasing an additional 2,894 shares in the last quarter. VestGen Advisors LLC purchased a new stake in shares of Alignment Healthcare during the third quarter worth approximately $135,000. Park Avenue Securities LLC increased its position in shares of Alignment Healthcare by 37.2% during the third quarter. Park Avenue Securities LLC now owns 59,635 shares of the company’s stock worth $487,000 after purchasing an additional 16,157 shares in the last quarter. Finally, Sterling Capital Management LLC raised its stake in Alignment Healthcare by 839.9% in the 3rd quarter. Sterling Capital Management LLC now owns 6,739 shares of the company’s stock valued at $55,000 after purchasing an additional 6,022 shares during the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Alignment reported third-quarter revenue of $1.36 billion, up 36.7% year over year and above the $1.31 billion analyst estimate. Adjusted EPS of a $0.04 loss matched consensus. Alignment Healthcare Reports Third Quarter 2026 Results
• Positive Sentiment: Management is targeting at least 20% top-line growth in 2027, supporting the company’s longer-term expansion narrative. Alignment Targets 2027 Growth
• Neutral Sentiment: Barclays reduced its price target from $10 to $9 while maintaining an “equal weight” rating, implying potential upside but limited conviction. Barclays Rating
• Negative Sentiment: Alignment lowered its 2026 adjusted EBITDA outlook to at least $100 million, signaling weaker near-term profitability and helping offset the revenue beat. Alignment EBITDA Outlook
• Negative Sentiment: CMS reduced the 2027 Star Rating for Alignment’s California HMO contract H3815 from 4.0 to 3.5 stars. The contract serves approximately 75% of membership, raising concerns about bonus eligibility, enrollment and reimbursement economics. Alignment H3815 CMS Rating Concerns
• Negative Sentiment: KeyCorp downgraded ALHC from “overweight” to “sector weight,” while multiple law firms announced investigations into possible securities-law violations. These notices are allegations and do not establish wrongdoing, but they add reputational and legal overhang. Alignment Investigation Notice

About Alignment Healthcare

Alignment Healthcare, Inc is a technology-enabled health insurance company focused on providing Medicare Advantage plans for seniors. The company combines health plan coverage with care coordination and clinical services designed to help members manage chronic conditions, access providers and navigate the health care system.

Its offerings include Medicare Advantage plans, supplemental benefits and member support services. Alignment also uses its proprietary technology platform, including the Alignment Virtual Application (AVA), to support care teams, analyze health information and help deliver more personalized services to members.

Founded in 2013, Alignment Healthcare serves Medicare-eligible consumers in selected markets, including California, Florida, Nevada and North Carolina.